MedCity News’ top headlines this week.
The light from a smartphone can cure acne? An app can determine the sex of an unborn baby? Shenanigans! One in five therapeutic health apps claimed to cure or treat a medical problem in this new study from Boston researchers.
In light of TED‘s 1 billionth video view, here’s “How I Repaired My Own Heart” and four other TEDtalks medical innovators will enjoy.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
An implantable neurostimulation device being developed by Minnesota startup Respicardia to treat central sleep apnea is almost ready for a pivotal trial.
An orthopedics company trying to make existing implant technology cheaper for hospitals and surgeons has raised about $4 million in anticipation of two 2013 product launches.
Agree to disagree: Here’s a comparison of two opposing Wall Street analysts’ viewpoints on St. Jude Medical‘s Durata ICD lead.
Tweets we liked this week.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Wisconsin won’t create a health insurance exchange huff.to/T6FKKQ #HCR
— Michelle Jackson (@MJ_analytics) November 16, 2012
Patrick Vallance @gsk talking about #openinnovation Have a 50:50 split of internal projects and external collaborations #OISBC
— Ceri Batchelder (@ceribatchelder) November 15, 2012
FDA clears first iPhone-enabled body thermometer shar.es/Gyzul#mHealth #digitalhealth #healthapps by @jonahcomstock
— Brian Dolan (@mobilehealth) November 16, 2012
Entrepreneurs expect #IPO from @practicefusion, @castlighthealth, @zocdoc shar.es/GYFTV via @mobilehealth #mhealth #digitalhealth
— Neil Versel (@nversel) November 13, 2012
We didn’t write these, but you should read them anyway.
Simply penalizing hospitals with high readmission rates isn’t the answers; some of these strategies might be (Open Placement blog)
The evolving CIO-CMIO relationship (Healthcare Informatics)
Pharma sales reps apparently need to mix it up in how they communicate with primary care physicians (PharmaLot)
Mobile health could halve the time and money needed for clinical trials (Life Science Leader)
